Comprehensive diagnostic model for osteosarcoma classification using CT imaging features
- PMID: 39109279
- PMCID: PMC11300932
- DOI: 10.1016/j.jbo.2024.100622
Comprehensive diagnostic model for osteosarcoma classification using CT imaging features
Abstract
Objective: The main objective of this study was to create and assess a detailed diagnostic model with an optimizing feature selection algorithm that combines computed tomography (CT) imaging characteristics, demographic information, and genetic markers to enhance the accuracy of benign and malignant classification of osteosarcoma. This research seeks to enhance the early identification and categorization of benign and malignant of osteosarcoma, ultimately enabling more personalized and efficient treatment approaches.
Methods: Data from 225 patients diagnosed with osteosarcoma at two different medical institutions between June 2018 and June 2021 were gathered for this research study. A novel feature selection approach that combined Principal Component Analysis (PCA) with Improved Particle Swarm Optimization (IPSO) was utilized to analyze 1743 image-derived features. The performance of the resulting model was evaluated using metrics such as area under the receiver operating characteristic curve (AUC), accuracy (ACC), sensitivity (SEN), and specificity (SPE), and compared to models developed using conventional feature selection methods.
Results: The proposed model showed promising predictive performance with an AUC of 0.87, accuracy of 0.80, sensitivity of 0.75, and specificity of 0.85. These results suggest improved predictive ability compared to models built using traditional feature selection techniques, particularly in terms of accuracy and specificity. However, there is room for improvement in enhancing sensitivity.
Conclusion: Our study introduces a novel predictive model for distinguishing between benign and malignant osteosarcoma., emphasizing its potential significance in clinical practice. Through the utilization of CT imaging features, our model shows improved accuracy and specificity, marking progress in the early detection and classification of osteosarcoma as either benign or malignant. Future investigations will concentrate on enhancing the model's sensitivity and validating its effectiveness on a larger dataset, aiming to boost its clinical relevance and support personalized treatment approaches for osteosarcoma.
Keywords: Computed tomography (CT); Machine learning; Osteosarcoma; Particle swarm optimizer (PSO).
© 2024 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma in contrast-enhanced MDCT images using quantitative feature classification.Med Phys. 2017 Jul;44(7):3604-3614. doi: 10.1002/mp.12258. Epub 2017 Jun 9. Med Phys. 2017. PMID: 28376281
-
Computed tomography and guidelines-based human-machine fusion model for predicting resectability of the pancreatic cancer.J Gastroenterol Hepatol. 2024 Feb;39(2):399-409. doi: 10.1111/jgh.16401. Epub 2023 Nov 13. J Gastroenterol Hepatol. 2024. PMID: 37957952
-
Automatic classification of spinal osteosarcoma and giant cell tumor of bone using optimized DenseNet.J Bone Oncol. 2024 May 11;46:100606. doi: 10.1016/j.jbo.2024.100606. eCollection 2024 Jun. J Bone Oncol. 2024. PMID: 38778836 Free PMC article.
-
Artificial intelligence in clinical care amidst COVID-19 pandemic: A systematic review.Comput Struct Biotechnol J. 2021;19:2833-2850. doi: 10.1016/j.csbj.2021.05.010. Epub 2021 May 7. Comput Struct Biotechnol J. 2021. PMID: 34025952 Free PMC article. Review.
-
A Comprehensive Review of Advancements in Diagnostic Imaging: Unveiling Oral Cavity Malignancies Using Computed Tomography.Cureus. 2024 Jul 7;16(7):e64045. doi: 10.7759/cureus.64045. eCollection 2024 Jul. Cureus. 2024. PMID: 39114200 Free PMC article. Review.
Cited by
-
Artificial Intelligence in Primary Malignant Bone Tumor Imaging: A Narrative Review.Diagnostics (Basel). 2025 Jul 4;15(13):1714. doi: 10.3390/diagnostics15131714. Diagnostics (Basel). 2025. PMID: 40647712 Free PMC article. Review.
References
-
- Beird H.C., et al. Osteosarcoma. Nat. Rev. Dis. Primers. 2022;8(1):77. - PubMed
-
- Gill J., Gorlick R. Advancing therapy for osteosarcoma. Nat. Rev. Clin. Oncol. 2021;18(10):609–624. - PubMed
-
- A.C. Ferreira, M. Cohen-Solal, P.C. D’Haese, A. Ferreira, a. i. o. t. C.-M. w. g. o. t. E.-E. European Renal Osteodystrophy, The role of bone biopsy in the management of CKD-MBD, Calcified Tissue Inte., 108(4) (2021), 528–538. - PubMed
-
- Wennmann M., et al. Prediction of bone marrow biopsy results from MRI in multiple myeloma patients using deep learning and radiomics. Invest. Radiol. 2023;58(10):754–765. - PubMed
LinkOut - more resources
Full Text Sources